Financial Designs
SLS icon

Financial Designs’s SELLAS Life Sciences SLS Stock Holding History

Financial Designs’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$236K Sell
19,186
-4,141
-18% -$51.9K 0.12% 37
2026
Q2 		$344K Hold
23,327
– – 0.18% 29
2026
Q1 		$98.7K Buy
+23,327
New +$104K 0.05% 40

Other funds holding SLS

DI
DAGCO Inc Westlake, Ohio $576M AUM 21.79% 1-Year Est. Return
Opus Capital Group
Opus Capital Group Cincinnati, Ohio $1.02B AUM 13.75% 1-Year Est. Return
Everhart Financial Group
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Fulcrum Wealth Advisors
Fulcrum Wealth Advisors Bellevue, Washington $144M AUM 21.17% 1-Year Est. Return
Vision Financial Markets
Vision Financial Markets Stamford, Connecticut $131M AUM 8.71% 1-Year Est. Return
Accurate Wealth Management
Accurate Wealth Management Wesley Chapel, Florida $1.16B AUM 24.67% 1-Year Est. Return
Instrumental Wealth
Instrumental Wealth Tampa, Florida $206M AUM 16.83% 1-Year Est. Return
NAMP
NorthStar Asset Management (Pennsylvania) Blue Bell, Pennsylvania $553M AUM 22.48% 1-Year Est. Return

Financial Designs's SLS Position: Q3 2026 in Review

Financial Designs reduced its SELLAS Life Sciences (SLS) stake by 18% in Q3 2026, selling an estimated $51.9K and leaving 19,186 shares worth $236K. The position accounts for 0.12% of the portfolio, ranked #37.

Financial Designs first reported a position in SLS in Q1 2026 and has held it in 3 quarters since. The position peaked at $344K in Q2 2026. 48 funds tracked by Wall St. Rank hold SLS as of Q3 2026.

  • Financial Designs held 19,186 shares of SELLAS Life Sciences worth $236K as of Q3 2026.
  • Financial Designs sold 4,141 SELLAS Life Sciences shares in Q3 2026, an estimated $51.9K.
  • SELLAS Life Sciences made up 0.12% of Financial Designs's portfolio in Q3 2026, its #37 holding.
  • Financial Designs first reported a position in SELLAS Life Sciences in Q1 2026 and has held it in 3 quarters since.
  • Financial Designs's SELLAS Life Sciences position peaked at $344K in Q2 2026.
  • 48 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q3 2026.

Based on Financial Designs's 13F filing for Q3 2026, filed 9 Oct 2026.